Docetaxel Injection USP

Pharmacies, wholesalers, and distributors that stock oncology injectables need a product they can rely on for both quality and steady availability. Docetaxel Injection USP from Xiromed answers that need. This sterile antineoplastic injectable gives your inventory a dependable option backed by consistent manufacturing, clearly documented specifications, and the supply reliability your buyers count on when handling sensitive oncology products.

Product Overview

Docetaxel Injection USP is a sterile injectable antineoplastic agent intended for use in a clinical setting under the direction of qualified oncology professionals. As an injectable, it is prepared and administered by trained healthcare staff, which keeps the product firmly within the hospital pharmacy, specialty pharmacy, and authorized distribution channels where controlled handling is the norm.

Because Docetaxel Injection USP carries the USP designation, it is formulated to recognized United States Pharmacopeia standards. That gives buyers added assurance around quality, identity, and consistency, and it supports the documentation your compliance and procurement teams expect from a reliable supplier.

For distributors building out an oncology or antineoplastic category, this product slots in cleanly. It meets a recognized therapeutic need and arrives with the specifications your team relies on for accurate ordering. To confirm current pack sizes, vial configurations, and National Drug Codes for Docetaxel Injection USP, connect with the Xiromed team so you can match the exact configuration against your inventory systems before placing an order.

Active Ingredient and Its Role

The value of this product rests on a single, well-established active ingredient.

Docetaxel is a taxane-class antineoplastic agent used in the management of certain cancers. It belongs to a group of medicines that act on the way cells divide, and it has a long, well-recognized place in oncology practice. Because it is delivered by injection, the medication enters systemic circulation directly, allowing precise, clinician-controlled administration in the treatment setting.

As a cytotoxic agent, Docetaxel calls for careful handling throughout the supply chain and in the pharmacy. Trained staff prepare and administer it under established safety protocols, which makes reliable sourcing and clear labeling especially important for the buyers who stock it. Because the injection delivers the active ingredient in a fixed, standardized concentration, pharmacists and clinical teams can count on consistent product from one order to the next.

Indications and Use

Docetaxel Injection USP is a prescription antineoplastic injectable intended for use under the direction of a qualified healthcare professional experienced in the use of cancer chemotherapy agents. Products in this category are typically administered as part of oncology treatment regimens for indications defined in the approved product labeling.

Prescribing decisions, dosing, patient selection, premedication, monitoring, and treatment duration should always follow the approved product labeling and the clinical judgment of the treating physician. Because cytotoxic therapy requires specialized handling and close clinical oversight, administration should occur only in appropriate clinical settings under proper supervision. This description is written for licensed professionals and authorized trade partners and does not replace the full prescribing information. Always confirm indications, contraindications, warnings, and directions against the current labeling before dispensing or administering.

Pack Configuration and Key Details

Clear specifications reduce ordering errors and keep procurement moving. Confirm the following before adding Docetaxel Injection USP to your catalog:

• Product name: Docetaxel Injection USP
• Active ingredient: Docetaxel
• Dosage form: Sterile injectable solution
• Route of administration: Injection (for clinical administration)
• Category: Antineoplastic / oncology injectable
• Supplier: Xiromed
• Pack sizes and NDCs: Contact the Xiromed team to confirm current vial sizes and National Drug Codes

Because pack sizes and NDCs may vary, verify the exact configuration with Xiromed before ordering. That step keeps your reorder pattern clean and helps your team match shipments accurately against inventory systems, which matters even more for a controlled oncology product.

Why Source Through Xiromed

Reliable supply matters as much as the product itself, and it matters most in oncology, where handling and continuity are critical. Xiromed manufactures its portfolio to meet stringent regulatory standards, and Docetaxel Injection USP holds to the same benchmark. Each batch is produced with consistency in mind, so your supply chain receives a product that performs the same way order after order.

Sourcing Docetaxel Injection USP directly through Xiromed gives buyers verified specifications, confirmed product codes for accurate matching, and a supply relationship built around the demands of pharmacies, wholesalers, and distributors. When availability and documentation both matter, working with a manufacturer that prioritizes each makes procurement simpler.

If you are expanding your oncology injectable offering or securing a steady source for an existing line, Docetaxel Injection USP is a straightforward addition. To order or request further product information, including current vial sizes and NDCs, connect with the Xiromed team to confirm the exact configuration for your inventory.

This information is intended for licensed healthcare professionals, pharmacies, and authorized distributors. Docetaxel Injection USP is a prescription product and should be used only as directed by a qualified healthcare provider in accordance with the approved product labeling. Product availability, specifications, and regulatory status may vary by region. Refer to the full prescribing information before dispensing.